Relation between herpes simplex viruses and human immunodeficiency virus infections

被引:53
作者
Severson, JL
Tyring, SK
机构
[1] Univ Texas, Med Branch, Dept Dermatol, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
[3] Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77555 USA
关键词
D O I
10.1001/archderm.135.11.1393
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The rates of herpes simplex virus (HSV) infection are rising, the highest prevalence being in the group infected with the human immunodeficiency virus (HIV). We review the relation between these 2 infections. The presence of genital ulcers increases the transmission of HIV, and the presence of HIV adversely affects the natural history of HSV infection. The detection and treatment of sexually transmitted diseases such as genital herpes actually decrease the rates of HIV infection in groups studied. The treatment of HSV in persons with HIV is challenging because the incidence of immunosuppression increases. Acyclovir resistance is more common in this group, but acyclovir use may prolong survival in some HIV-seropositive patients. Further studies are needed to determine whether persons with HIV disease should routinely be given HSV-specific therapy.
引用
收藏
页码:1393 / 1397
页数:5
相关论文
共 70 条
[1]  
AMBINDER RF, 1984, LANCET, V1, P1154
[2]   PROGNOSTIC FACTORS IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS WITH A CD4(+) LYMPHOCYTE COUNT LESS-THAN-50/MU-L [J].
APOLONIO, EG ;
HOOVER, DR ;
HE, YH ;
SAAH, AJ ;
LYTER, DW ;
DETELS, R ;
KASLOW, RA ;
PHAIR, JP .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :829-836
[3]   INCREASED GENITAL SHEDDING OF HERPES-SIMPLEX VIRUS TYPE-2 IN HIV-SEROPOSITIVE WOMEN [J].
AUGENBRAUN, M ;
FELDMAN, J ;
CHIRGWIN, K ;
ZENILMAN, J ;
CLARKE, L ;
DEHOVITZ, J ;
LANDESMAN, S ;
MINKOFF, H .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (11) :845-847
[4]   RELATIONSHIP BETWEEN HERPES-SIMPLEX VIRUS ULCERATION AND CD4+ CELL COUNTS IN PATIENTS WITH HIV-INFECTION [J].
BAGDADES, EK ;
PILLAY, D ;
SQUIRE, SB ;
ONEIL, C ;
JOHNSON, MA ;
GRIFFITHS, PD .
AIDS, 1992, 6 (11) :1317-1320
[5]   CLINICAL AND LABORATORY EXPERIENCE WITH ACYCLOVIR-RESISTANT HERPES VIRUSES [J].
BARRY, DW ;
LEHRMAN, SN ;
ELLIS, MN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :75-84
[6]   Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204) [J].
Bell, WR ;
Chulay, JD ;
Feinberg, JE .
MEDICINE, 1997, 76 (05) :369-380
[7]   ACYCLOVIR SUSCEPTIBILITIES OF HERPES-SIMPLEX VIRUS-STRAINS ISOLATED FROM SOLID ORGAN TRANSPLANT RECIPIENTS AFTER ACYCLOVIR OR GANCICLOVIR PROPHYLAXIS [J].
BOIVIN, G ;
ERICE, A ;
CRANE, DD ;
DUNN, DL ;
BALFOUR, HH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :357-359
[8]   HERPES-SIMPLEX VIRUS TYPE-2 INFECTION, SYPHILIS, AND HEPATITIS-B VIRUS-INFECTION IN HAITIAN WOMEN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND HUMAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTIONS [J].
BOULOS, R ;
RUFF, AJ ;
NAHMIAS, A ;
HOLT, E ;
HARRISON, L ;
MAGDER, L ;
WIKTOR, SZ ;
QUINN, TC ;
MARGOLIS, H ;
HALSEY, NA .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) :418-420
[9]   Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine [J].
Brichacek, B ;
Swindells, S ;
Janoff, EN ;
Pirruccello, S ;
Stevenson, M .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1191-1199
[10]  
BURNSIDE A, 1998, 36 ANN M INF DIS SOC